ATOS - ATOSSA THERAPEUTICS, INC.
0.8312
-0.049 -5.847%
Share volume: 717,512
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.88
-0.05
-0.06%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-13-2024 | 08-14-2023 | 11-13-2023 | 11-12-2024 | 05-13-2024 | 08-12-2024 | 11-12-2024 | 03-25-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 7.098 M | 7.793 M | 7.468 M | 9.018 M | 6.980 M | 7.105 M | 6.385 M | 7.151 M | |
| Selling general and admin | 3.590 M | 4.088 M | 3.001 M | 3.364 M | 3.232 M | 3.552 M | 2.973 M | 3.747 M | |
| Research and development | 3.508 M | 3.705 M | 4.467 M | 5.654 M | 3.748 M | 3.553 M | 3.412 M | 3.404 M | |
| Total expenses | 7.098 M | 7.793 M | 7.468 M | 9.018 M | 6.980 M | 7.105 M | 6.385 M | 7.151 M | |
| 9.79% | -4.17% | 20.76% | -22.60% | 1.79% | -10.13% | 12.00% | |||
| Operating income | -7.098 M | -7.793 M | -7.468 M | -9.018 M | -6.980 M | -7.105 M | -6.385 M | -7.151 M | |
| Ebit | -7.131 M | -7.823 M | -7.503 M | -11.980 M | -7.016 M | -7.122 M | -8.231 M | -5.475 M | |
| Pretax income | -6.281 M | -9.830 M | -6.229 M | -7.754 M | -5.878 M | -6.049 M | -7.230 M | -6.347 M | |
| 56.50% | -36.63% | 24.48% | -24.19% | 2.91% | 19.52% | -12.21% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -6.281 M | -9.830 M | -6.229 M | -7.754 M | -5.878 M | -6.049 M | -7.230 M | -6.347 M | |
| -56.50% | 36.63% | -24.48% | 24.19% | -2.91% | -19.52% | 12.21% |
